Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Driven Brands (NASDAQ: DRVN) Adds Shareholder Returns to Take 5 Growth Strategy

Driven Brands Holdings Inc. (NASDAQ: DRVN) has authorized up to $100 million in common stock repurchases, adding shareholder returns to its updated capital allocation priorities. The authorization took effect on September 15, 2026, while the company continues to invest in Take 5 growth.

Vinay Lochav | 16 September 2026

FG Nexus (NASDAQ: FGNX) Repurchased Common Shares Equaling 46% of Pre-Program Shares

FG Nexus Inc. (NASDAQ: FGNX) has repurchased approximately 4.0 million common shares for approximately $48.0 million, including commissions. Those purchases represent approximately 46% of the shares outstanding immediately before the common-stock program began.

Vinay Lochav | 16 September 2026

Bandwidth Inc. (NASDAQ: BAND) Plans 2026 Investor Presentation for Conferences

The materials will be available on the company’s investor-relations website and include discussion of cloud communications, AI voice and messaging.

Vinay Lochav | 16 September 2026

Alnylam Pharmaceuticals (NASDAQ:ALNY) Brings RNA-Based Medicines Into the Nasdaq 100 Growth Debate

Alnylam Pharmaceuticals (NASDAQ:ALNY) pioneered an entirely new class of medicine, drugs that silence disease-causing genes, and it is now turning that science into fast-growing commercial products. As those medicines reach more patients, Alnylam brings the promise of RNA-based therapies into theNasdaq100 growth debate, offering …

Nitish Kishor | 16 September 2026

Brenton John: Nano Dimension CFO Retains 403,762 Shares After Insider Transaction

Nano Dimension Ltd. CFO Brenton John forfeited 17,029 shares at $1.54 per share. The transaction was recorded on September 14, 2026.

Vinay Lochav | 16 September 2026

Amgen's (NASDAQ:AMGN) Drug Pipeline Matters for the Company's Next Chapter

Amgen's (NASDAQ:AMGN) next chapter will be written by its pipeline, and one experimental medicine in particular has captured investors' attention: a monthly obesity injection that could let the company compete in one of the fastest-growing markets in healthcare. ForNasdaq100 investors, Amgen is a reminder …

Nitish Kishor | 16 September 2026

Cogent Communications (NASDAQ: CCOI) VP Retains 36,200 Shares After September 15 Sale

Cogent Communications Holdings, Inc. (NASDAQ: CCOI) saw VP of Network Strategy Henry W. Kilmer sell 2,400 shares at $9.21 each on September 15, 2026.

Vinay Lochav | 16 September 2026

CalciMedica, Niagen Bioscience, Anavex, Akebia and Upstream Bio Chart Divergent Paths in Biotech

● CalciMedica completed a one-for-fiveReverse Stock Spliteffective 31 August 2026 while reporting FDA alignment on a Phase 2b Auxora trial design and a roughly $49 million private placement.

Nitish Kishor | 16 September 2026

CoreWeave (NASDAQ: CRWV) CFO Exercises Options on September 11, Sells Shares September 14

CoreWeave, Inc. (NASDAQ: CRWV) CFO Nitin Agrawal exercised options covering 122,340 shares, leaving him with 254,936 shares after the transaction. The exercise represented about 48.0% of his resulting share holding.

Vinay Lochav | 16 September 2026

Cadrenal, Upexi, PDS Biotechnology, GeoVax and Atossa Navigate Cash Runway and Clinical Resets

● Cadrenal Therapeutics reported about $2.3 million in cash at 31 March 2026 and lined up an up-to-$8.8 million privatePlacementto extend its runway toward 2027.

Nitish Kishor | 16 September 2026
Support

Hi! How can we help you today?

Loading…